Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Peroxisome Proliferator-Activated Receptor γ Agonist Provides Superior Renal Protection versus Angiotensin-Converting Enzyme Inhibition in a Rat Model of Type 2 Diabetes with Obesity
Chris Baylis, Elke-Astrid Atzpodien, Gary Freshour and Kevin Engels
Journal of Pharmacology and Experimental Therapeutics December 2003, 307 (3) 854-860; DOI: https://doi.org/10.1124/jpet.103.055616